Metropolis Healthcare Limited Stock
Equities
METROPOLIS
INE112L01020
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,924.20 INR | -0.36% |
|
-0.35% | -7.34% |
| Capitalization | 99.72B 1.11B 952M 892M 832M 1.54B 1.67B 10.44B 4.03B 47.09B 4.16B 4.07B 172B | P/E ratio 2026 * |
49.4x | P/E ratio 2027 * | 39.3x |
|---|---|---|---|---|---|
| Enterprise value | 98.18B 1.09B 938M 878M 819M 1.51B 1.64B 10.27B 3.97B 46.37B 4.09B 4.01B 170B | EV / Sales 2026 * |
5.94x | EV / Sales 2027 * | 5.13x |
| Free-Float |
50.58% | Yield 2026 * |
0.41% | Yield 2027 * | 0.53% |
Last Transcript: Metropolis Healthcare Limited
| 1 day | -0.36% | ||
| 1 week | -0.35% | ||
| Current month | -0.35% | ||
| 1 month | -4.07% | ||
| 3 months | -12.77% | ||
| 6 months | +16.46% | ||
| Current year | -7.34% |
| 1 week | 1,904.5 |  | 1,969.1 |
| 1 month | 1,904.5 | | 1,990 |
| Current year | 1,315 | | 2,263 |
| 1 year | 1,315 | | 2,263 |
| 3 years | 1,171.35 | | 2,318.3 |
| 5 years | 1,171.35 | | 3,579.9 |
| 10 years | 907 | | 3,579.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2023-01-01 | |
| Compliance Officer | - | 2024-02-02 | |
Kirti Chadha
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 2004-12-31 | |
| Chairman | 45 | 2024-05-21 | |
| Director/Board Member | 59 | 2017-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.36% | -0.35% | -9.89% | +33.15% | 1.11B | |
| +1.03% | +2.40% | +42.47% | +530.28% | 33.75B | |
| +0.26% | -0.94% | -19.11% | -26.75% | 7.57B | |
| -3.07% | -5.07% | -3.70% | +279.11% | 6.06B | |
| -1.85% | -4.79% | +105.91% | +1,491.86% | 4.59B | |
| -0.80% | -0.73% | -1.25% | +21.86% | 2.81B | |
| +0.67% | -2.78% | -16.37% | -59.19% | 1.88B | |
| -2.22% | -1.65% | -33.00% | +2.94% | 1.54B | |
| +0.77% | -9.72% | +10.70% | -8.68% | 1.46B | |
| +1.40% | -3.97% | +16.50% | -39.91% | 1.32B | |
| Average | -0.42% | -2.64% | +9.23% | +222.47% | 6.21B | |
| Weighted average by Cap. | +0.13% | -0.10% | +27.28% | +421.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.52B 184M 158M 148M 138M 254M 277M 1.73B 668M 7.8B 689M 674M 28.53B | 18.71B 208M 179M 167M 156M 288M 313M 1.96B 756M 8.84B 780M 764M 32.31B |
| Net income | 2.01B 22.37M 19.23M 18.01M 16.79M 31.01M 33.73M 211M 81.35M 951M 83.95M 82.16M 3.48B | 2.54B 28.22M 24.26M 22.73M 21.18M 39.13M 42.56M 266M 103M 1.2B 106M 104M 4.39B |
| Net Debt | -1.54B -17.08M -14.68M -13.75M -12.82M -23.67M -25.75M -161M -62.1M -726M -64.09M -62.72M -2.65B | -3.72B -41.34M -35.54M -33.29M -31.03M -57.31M -62.34M -389M -150M -1.76B -155M -152M -6.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 1,924.20 ₹ | -0.36% | 13,375 |
| 25-12-04 | 1,931.10 ₹ | -0.75% | 75,543 |
| 25-12-03 | 1,945.70 ₹ | +0.33% | 31,397 |
| 25-12-02 | 1,939.30 ₹ | -0.88% | 18,299 |
| 25-12-01 | 1,956.60 ₹ | +1.33% | 35,566 |
End-of-day quote NSE India S.E., December 04, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- METROPOLIS Stock
Select your edition
All financial news and data tailored to specific country editions
